- Home
- CTNM vs FTEL Comparison
CTNM vs FTEL Comparison
Compare CTNM & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- FTEL
- Stock Information
- Founded
- CTNM 2009
- FTEL 2007
- Country
- CTNM United States
- FTEL Australia
- Employees
- CTNM N/A
- FTEL N/A
- Industry
- CTNM
- FTEL
- Sector
- CTNM
- FTEL
- Exchange
- CTNM Nasdaq
- FTEL Nasdaq
- Market Cap
- CTNM 199.3M
- FTEL 207.1M
- IPO Year
- CTNM 2024
- FTEL 2023
- Fundamental
- Price
- CTNM $7.59
- FTEL $0.91
- Analyst Decision
- CTNM Strong Buy
- FTEL
- Analyst Count
- CTNM 4
- FTEL 0
- Target Price
- CTNM $29.25
- FTEL N/A
- AVG Volume (30 Days)
- CTNM 56.2K
- FTEL 2.3M
- Earning Date
- CTNM 03-04-2025
- FTEL 03-28-2025
- Dividend Yield
- CTNM N/A
- FTEL N/A
- EPS Growth
- CTNM N/A
- FTEL N/A
- EPS
- CTNM N/A
- FTEL N/A
- Revenue
- CTNM N/A
- FTEL $4,466,775.00
- Revenue This Year
- CTNM N/A
- FTEL N/A
- Revenue Next Year
- CTNM N/A
- FTEL N/A
- P/E Ratio
- CTNM N/A
- FTEL N/A
- Revenue Growth
- CTNM N/A
- FTEL N/A
- 52 Week Low
- CTNM $7.04
- FTEL $0.63
- 52 Week High
- CTNM $22.00
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- FTEL 25.90
- Support Level
- CTNM N/A
- FTEL $0.87
- Resistance Level
- CTNM N/A
- FTEL $1.42
- Average True Range (ATR)
- CTNM 0.00
- FTEL 0.99
- MACD
- CTNM 0.00
- FTEL -0.10
- Stochastic Oscillator
- CTNM 0.00
- FTEL 2.92
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.